Interested in a collaboration?
Contact us to discuss the possibilities.
The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...
Employees from RTM and Radboudumc have published a new article: 'Production of novel diagnostic radi...
Klaudia Cybulska (postdoc radiochemistry) has written an article about Huntington's Disease. Abstra...
We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....
Contact us to discuss the possibilities.